On the treatment of Diabetus mellitus by acid extract of Duodenal Mucous Membrane.
作者信息
Moore B
机构信息
University of Liverpool.
出版信息
Biochem J. 1906;1(1):28-38. doi: 10.1042/bj0010028.
Abstract
摘要
相似文献
1
On the treatment of Diabetus mellitus by acid extract of Duodenal Mucous Membrane.十二指肠黏膜酸提取物治疗糖尿病
Biochem J. 1906;1(1):28-38. doi: 10.1042/bj0010028.
2
Further Observations on the Treatment of Diabetes Mellitus by Acid Extract of Duodenal Mucous Membrane.十二指肠黏膜酸提取物治疗糖尿病的进一步观察
Biochem J. 1906;1(8-9):446-54. doi: 10.1042/bj0010446.
3
Acid Extract of the Duodenal Mucous Membrane as a Remedy in Diabetes Mellitus.十二指肠黏膜酸提取物作为糖尿病的一种治疗方法。
Hospital (Lond 1886). 1906 Feb 10;39(1011):319-320.
4
[Heredity in diabetus mellitus].[糖尿病中的遗传因素]
Nord Med. 1951 Jul 11;46(28):1059-63.
5
[Anatomo-stereologic characteristics of the mucous membrane of the major duodenal papilla].[十二指肠大乳头黏膜的解剖立体学特征]
Arkh Anat Gistol Embriol. 1986 Mar;90(3):61-6.
6
[Diabetus mellitus and pregnancy].[糖尿病与妊娠]
Nord Med. 1953 Apr 10;49(15):533-6.
7
[Cornea in diabetus mellitus].[糖尿病中的角膜]
Oftalmologia. 2011;55(3):3-11.
8
Diabetus mellitus in the services.服务中的糖尿病。 （不过原句“Diabetus mellitus”拼写有误，正确的是“Diabetes mellitus”，意为“糖尿病” ）
J R Army Med Corps. 1991 Jun;137(2):107.
9
10
[Our 1st experience with chlorpropamide in the treatment of diabetus mellitus].[我们使用氯磺丙脲治疗糖尿病的首次经验]
Med Glas. 1962 Feb;16:80-3.
引用本文的文献
1
New Perspectives in Modulating the Entero-Insular Axis in Pediatric Obesity.调节小儿肥胖症肠-胰岛轴的新视角
Int J Mol Sci. 2025 Jun 26;26(13):6143. doi: 10.3390/ijms26136143.
2
GLP-1R in diabetes mellitus: from basic discovery to therapeutics development.糖尿病中的胰高血糖素样肽-1受体：从基础发现到治疗药物开发
Front Pharmacol. 2025 May 30;16:1610512. doi: 10.3389/fphar.2025.1610512. eCollection 2025.
3
Glucose-dependent insulinotropic polypeptide (GIP).葡萄糖依赖性促胰岛素多肽（GIP）。
Mol Metab. 2025 May;95:102118. doi: 10.1016/j.molmet.2025.102118. Epub 2025 Feb 28.
4
Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease.肠促胰岛素生理中的葡萄糖依赖性促胰岛素多肽：在健康与疾病中的作用
Endocr Rev. 2025 Jul 15;46(4):479-500. doi: 10.1210/endrev/bnaf006.
5
Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus.胰高糖素样肽-1受体激动剂治疗2型糖尿病的研究进展
Front Pharmacol. 2025 Jan 20;15:1483792. doi: 10.3389/fphar.2024.1483792. eCollection 2024.
6
Integration of Glucagon-Like Peptide 1 Receptor Actions Through the Central Amygdala.通过中央杏仁核整合胰高血糖素样肽1受体的作用
Endocrinology. 2025 Feb 5;166(3). doi: 10.1210/endocr/bqaf019.
7
Transforming obesity: The advancement of multi-receptor drugs.转变肥胖：多受体药物的进步。
Cell. 2024 Jul 25;187(15):3829-3853. doi: 10.1016/j.cell.2024.06.003.
8
The Regulation of Metabolic Homeostasis by Incretins and the Metabolic Hormones Produced by Pancreatic Islets.肠促胰岛素和胰岛产生的代谢激素对代谢稳态的调节
Diabetes Metab Syndr Obes. 2024 Jun 13;17:2419-2456. doi: 10.2147/DMSO.S415934. eCollection 2024.
9
Special Issue: "Anti-inflammatory Effects of Glucagon-like Peptide-1".特刊：“胰高血糖素样肽-1 的抗炎作用”。
Int J Mol Sci. 2024 Feb 7;25(4):1997. doi: 10.3390/ijms25041997.
10
Pharmacological Advances in Incretin-Based Polyagonism: What We Know and What We Don't.基于肠促胰岛素的多重作用的药理学进展：我们所知与未知
Physiology (Bethesda). 2024 May 1;39(3):142-156. doi: 10.1152/physiol.00032.2023. Epub 2024 Feb 14.
Zotero 插件